Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells

International Journal of Oncology
Young Il KimByung-Nam Cho

Abstract

Although inhibin was first identified as a hormone regulating pituitary FSH secretion, it was later recognized to act as a tumor suppressor in the gonad and adrenal glands. Recently, the alpha subunit of this dimeric hormone (inhibin‑α) was reported to be involved in prostate tumorigenesis. To identify additional roles outside the reproductive axis, we investigated inhibin‑α gene activity and subsequent cell fate in human gastric cancer cells. The results were as follows: all the gastric cancer cells had at least one of a set of abnormalities including hypermethylation of the promoter, mutation of the 5'‑UTR or allelic imbalance including LOH in the inhibin‑α gene. Hypermethylation of the promoter and mutation of the 5'‑UTR in inhibin‑α were observed in SNU‑1, SNU‑5 and SNU‑484 cells. LOH was observed in AGS, KATO III, SNU‑5, SNU‑484 and SNU‑668 cells. Treatment with 5‑AzaC, a demethylating agent, induced demethylation of the inhibin‑α promoter in the SNU‑1, SNU‑5 and SNU‑484 cell lines, with the CpG5 site being strongly influenced by 5‑AzaC. In addition, inhibin‑α mRNA and protein were maintained at low levels in most of the gastric cancer cell lines. These low levels of mRNA and protein expression could be increased in most l...Continue Reading

References

Oct 1, 1989·Endocrinology·D M RobertsonD M de Kretser
Dec 1, 1987·Proceedings of the Society for Experimental Biology and Medicine·S Y Ying
Jan 17, 1995·Biochemical and Biophysical Research Communications·G H ttenJ Pohl
Aug 11, 1994·Nucleic Acids Research·S J ClarkM Frommer
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·M M MatzukA Bradley
Nov 21, 1996·Biochemical and Biophysical Research Communications·J FangJ Bonadio
Dec 12, 2001·Endocrine Reviews·G P RisbridgerD M Robertson
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Jun 5, 2002·Molecular and Cellular Endocrinology·J K FindlayJ-F Ethier
Aug 22, 2002·Human Genetics·George A GarinisPanayiotis G Menounos
Nov 22, 2002·Biology of Reproduction·Alejandra M VitaleMarta Tesone
Dec 25, 2002·Human Reproduction Update·D M de KretserD J Phillips
Feb 10, 2004·Journal of Molecular Endocrinology·P BalanathanG P Risbridger
Jul 21, 2005·The Journal of Clinical Endocrinology and Metabolism·Corrine K WeltAlan L Schneyer
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K ZhuN Inaba
Aug 4, 2006·Reproduction : the Official Journal of the Society for the Study of Fertility·Phil G Knight, Claire Glister
Sep 9, 2006·American Journal of Obstetrics and Gynecology·Benjamin D HamarCatalin S Buhimschi
May 3, 2007·The Journal of Clinical Endocrinology and Metabolism·Anastasia TsigkouFelice Petraglia
May 25, 2007·Cancer Research·Nadine HempelGerard C Blobe
Apr 24, 2008·Advances in Clinical Chemistry·Anastasia TsigkouFelice Petraglia
Aug 12, 2009·Developmental Biology·Michelle MyersStephanie A Pangas
Dec 17, 2009·Trends in Endocrinology and Metabolism : TEM·Kaye L Stenvers, Jock K Findlay
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg

❮ Previous
Next ❯

Citations

Mar 13, 2012·Cancer Letters·Mario MenschikowskiGabriele Siegert
Mar 6, 2017·International Journal of Oncology·Young Il KimHee Joo Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Mitsutoshi KadowakiThomas E Eling
International Journal of Oncology
Yasuhiro OshimoW Yasui
International Journal of Cancer. Journal International Du Cancer
Eriko Okochi-TakadaToshikazu Ushijima
© 2021 Meta ULC. All rights reserved